PANACHE - Bayer Protocol 17582: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Dose-Finding Phase II Trial to Study the Efficacy, Safety, Pharmacokinetic and Pharmacodynamic Effects of the Oral Partial Adenosine A1 Receptor

Project: Research project

Project Details

StatusFinished
Effective start/end date9/12/17 → 3/20/19

Funding

  • Bayer HealthCare Pharmaceuticals, Inc. (Bayer Protocol 17582)